German healthcare company Siemens Healthineers and US-based medical device maker Stryker have teamed up to advance robotic systems for neurovascular interventions.
The collaboration focuses on developing a robotic system for both elective and emergency neurovascular procedures, including stroke and aneurysm treatments.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Siemens Healthineers brings its expertise in robotics and image-guided therapy, while Stryker contributes its knowledge in neurovascular technologies.
The initiative aims to integrate robotic systems, imaging, and therapeutic devices to enhance procedural precision, thereby improving patient outcomes in complex haemorrhagic cases and time-sensitive ischemic strokes.
Stryker neurovascular division president Jim Marucci said: “Stryker and Siemens Healthineers have the joint goal to advance neurovascular care through innovation.
“By combining our deep expertise in stroke therapy devices with the leadership of Siemens Healthineers in robotics and imaging, we aim to simplify workflows, enhance precision, and accelerate care.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“Together, we are taking an important step toward transforming how neurovascular procedures are performed – and ultimately, working to improve outcomes for patients worldwide.”
The partnership addresses the complexity of current neurovascular procedures, which often require physicians to manage multiple systems and tools.
By developing a single ecosystem, the companies intend to streamline these procedures, potentially reducing treatment times and improving accuracy.
The initial phase will involve the co-development of the integrated system and clinical validation alongside leading physicians.
Siemens Healthineers Advanced Therapies head Carsten Bertram said: “Neurovascular diseases – primarily strokes and aneurysms – carry a massive global burden. Stroke is the second-leading cause of death and the third-leading cause of disability in adults globally.
“Together, we are uniquely positioned to create an ecosystem of image-guidance, robotics and devices. This meaningful innovation will enable physicians to deliver more precise and timely care to patients around the world.”
The collaboration follows a recent announcement by Siemens Healthineers and Cook Medical to establish a new standard in interventional medicine.
They are creating the Interventional MRI (iMRI) Suite that aims to transform minimally invasive procedures.
